Takeda plans to dominate thriving Russian pharma market, starting with a new plant
Takeda has opened a new $96m (€75m) pharma facility in Russia as part of its bid to “outgrow” the already thriving local market.
Archives for September 10, 2012
Contract manufacturing facility additions: round-up
Outsourcing-Pharma.com brings you a round-up of the latest contract manufacturing facility additions, including news from Boehringer Ingelheim, Cambridge Major Laboratories, and B. Braun Group.
Eckert & Ziegler boosts early phase offering with Vitalea Science takeover
Isotope technology firm Eckert & Ziegler has acquired bioanalytical CRO Vitalea Science.